AstraZeneca COVID-19 Vaccine and mRNA COVID-19 vaccines showed similar and favorable safety profiles in a population-based cohort study of over a million people

Safety profiles of AstraZeneca’s COVID-19 Vaccine, and the mRNA-based vaccine were similar and overall favorable. Very rare clotting disorders (TTS) were observed with both vaccines but these were in line with what would be expected in the general population and lower than in those diagnosed with COVID-19.

Continue reading...

1 30 31 32 33 34 67